Foghorn Therapeutics GAAP EPS of $0.80, revenue of $83.5M
at seekingalpha.com (Mon, 9-Nov 7:59 AM)
Foghorn Therapeutics Reports Third-Quarter Financial and Corporate Update
at www.tipranks.com (Mon, 9-Nov 7:35 AM)
